Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: Eritoran in Severe Sepsis
NCT00334828Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2006
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 24
01
Overview
A Phase 3 trial of eritoran in sepsis, sponsored by Eisai Co., Ltd.. Started Jun 2006; status: completed.
02
Drugs
eritoran
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00334828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334828.